LOGIN
EFORT: Intra-articular TXA reduces total blood loss in patients undergoing TKA
June 2014
EFORT: Intra-articular TXA reduces total blood loss in patients undergoing TKA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
A prospective randomised double blinded placebo-controlled trial studying efficacy and safety of intra-articular injection of tranexamic acid in unilateral total knee arthroplasty
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
53 patients undergoing primary total knee arthroplasty were randomized to receive an intra-articular injection of either tranexamic acid (TXA; 1000 mg/20 mL) or a saline solution to determine the clinical efficacy of TXA with respect to total blood loss, the requirement for blood transfusion and the incidence of deep venous thrombosis (DVT). The results from this study indicated that the TXA group...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.